The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Open accessAbstract
Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody-dependent cellular cytotoxicity (ADCC) that may contribute to viral containment, we profiled an array of extra-neutralizing antibody effector functions across HIV-infected populations with varying degrees of viral control to define the characteristics of antibodies associated with spontaneous control. While neither the overall magnitude of antibody titer nor individual effector functions were increased in ECs, a more functionally coordinated innate immune-recruiting response was observed. Specifically, ECs demonstrated polyfunctional humoral immune responses able to coordinately recruit ADCC, other NK functions, monocyte and neutrophil phagocytosis, and complement. This functionally coordinated response was associated with qualitatively superior IgG3/IgG1 responses, whereas HIV-specific IgG2/IgG4 responses, prevalent among viremic subjects, were associated with poorer overall antibody activity. Rather than linking viral control to any single activity, this study highlights the critical nature of functionally coordinated antibodies in HIV control and associates this polyfunctionality with preferential induction of potent antibody subclasses, supporting coordinated antibody activity as a goal in strategies directed at an HIV-1 functional cure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011
Pereyra, F., Addo, M. M., Kaufmann, D. E., Liu, Y., Miura, T., Rathod, A., Baker, B., Trocha, A., Rosenberg, R., Mackey, E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/526786 · Cited by 540
Self-citationA robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Ackerman, M. E., Moldt, B., Wyatt, R. T., Dugast, A.-S., McAndrew, E., Tsoukas, S., Jost, S., Berger, C. T., Sciaranghella, G., Liu, Q., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.016 · Cited by 450
Self-citationYates, N. L., Liao, H.-X., Fong, Y., deCamp, A., Vandergrift, N. A., Williams, W. T., Alam, S. M., Ferrari, G., Yang, Z.-Y., Seaton, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007730 · Cited by 450
Chung, A. W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M. K., Rolland, M., Suscovich, T. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007736 · Cited by 406
Self-citationTomaras, G. D., Ferrari, G., Shen, X., Alam, S. M., Liao, H.-X., Pollara, J., Bonsignori, M., Moody, M. A., Fong, Y., Chen, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301456110 · Cited by 394
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Ackerman, M. E., Crispin, M., Yu, X., Baruah, K., Boesch, A. W., Harvey, D. J., Dugast, A.-S., Heizen, E. L., Ercan, A., Choi, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65708 · Cited by 358
Self-citationBarouch, D. H., Stephenson, K. E., Borducchi, E. N., Smith, K., Stanley, K., McNally, A. G., Liu, J., Abbink, P., Maxfield, L. F., Seaman, M. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.061 · Cited by 342
Self-citationProtective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
Barouch, D. H., Alter, G., Broge, T., Linde, C., Ackerman, M. E., Brown, E. P., Borducchi, E. N., Smith, K. M., Nkolola, J. P., Liu, J., et al. (2015) · Science · doi:10.1126/science.aab3886 · Cited by 297
Self-citationGómez-Román, V. R., Patterson, L. J., Venzon, D., Liewehr, D., Aldrich, K., Florese, R., & Robert-Guroff, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2185 · Cited by 276
Baum, L. L., Cassutt, K. J., Knigge, K., Khattri, R., Margolick, J., Rinaldo, C., Kleeberger, C. A., Nishanian, P., Henrard, D. R., & Phair, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2168 · Cited by 271
Mabuka, J., Nduati, R., Odem-Davis, K., Peterson, D., & Overbaugh, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002739 · Cited by 234
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
Brown, E. P., Licht, A. F., Dugast, A.-S., Choi, I., Bailey-Kellogg, C., Alter, G., & Ackerman, M. E. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.09.007 · Cited by 231
Self-citationHocqueloux, L., Prazuck, T., Avettand-Fenoel, V., Lafeuillade, A., Cardon, B., Viard, J.-P., & Rouzioux, C. (2010) · AIDS · doi:10.1097/qad.0b013e32833b61ba · Cited by 215
Gómez-Román, V. R., Florese, R. H., Patterson, L. J., Peng, B., Venzon, D., Aldrich, K., & Robert-Guroff, M. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.09.018 · Cited by 202
García, F., Plana, M., Ortiz, G. M., Bonhoeffer, S., Soriano, A., Vidal, C., Cruceta, A., Arnedo, M., Gil, C., Pantaleo, G., et al. (2001) · AIDS · doi:10.1097/00002030-200106150-00002 · Cited by 193
Milligan, C., Richardson, B. A., John-Stewart, G. C., Nduati, R. W., & Overbaugh, J. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.002 · Cited by 126
Tyler, D. S., Stanley, S., Nastala, C. A., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3375 · Cited by 103
Ackerman, M. E., Dugast, A., McAndrew, E. G., Tsoukas, S., Licht, A. F., Irvine, D. J., & Alter, G. (2013) · Journal of Virology · doi:10.1128/jvi.03403-12 · Cited by 102
Self-citationMultiple HIV-1-specific IgG3 responses decline during acute HIV-1
Yates, N. L., Lucas, J. T., Nolen, T. L., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834b348e · Cited by 98
Scharf, O., Golding, H., King, L. R., Eller, N. L., Frazier, D., Golding, B., & Scott, D. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6558-6565.2001 · Cited by 96
Ljunggren, K., Broliden, P. A., Morfeldt-Månson, L., Jondal, M., & Wahrén, B. (1988) · PubMed · Cited by 86
Forthal, D. N., Landucci, G., & Keenan, B. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220151126661 · Cited by 77
Cellular and humoral responses to tetanus vaccination in gabonese children
van Riet, E., Retra, K., Adégnika, A. A., der Zijde, C. M. J., Uh, H., Lell, B., Issifou, S., Kremsner, P. G., Yazdanbakhsh, M., van Tol, M. J. D., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.067 · Cited by 51
Dugast, A., Stamatatos, L., Tonelli, A., Suscovich, T. J., Licht, A. F., Mikell, I., Ackerman, M. E., Streeck, H., Klasse, P. J., Moore, J. P., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344305 · Cited by 50
Self-citationExploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication
Euler, Z., & Alter, G. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0235 · Cited by 46
Self-citationChoi, I., Chung, A. W., Suscovich, T. J., Rerks‐Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., O’Connell, R. J., Francis, D. P., Robb, M. L., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004185 · Cited by 45
Self-citationStructured Treatment Interruption in Patients Infected with HIV: A New Approach to Therapy
Gulick, R. M. (2002) · Drugs · doi:10.2165/00003495-200262020-00001 · Cited by 39
Miranda, L. R., Duval, M., Doherty, H., Seaman, M. S., Posner, M. R., & Cavacini, L. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7132 · Cited by 32
Cavacini, L. A., Emes, C. L., Power, J., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3638 · Cited by 31
Liu, F., Lopez‐Bergami, P., Duval, M., et al. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203322230969 · Cited by 26
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life
Boesch, A. W., Alter, G., & Ackerman, M. E. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000149 · Cited by 23
Self-citation
Cited by
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Self-citationNatural killer cells in antiviral immunity
Björkström, N. K., Strunz, B., & Ljunggren, H.-G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00558-3 · Cited by 503
The Immunoregulatory Roles of Antibody Glycosylation
Jennewein, M. F., & Alter, G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.004 · Cited by 323
Self-citationCD8+ T cells in HIV control, cure and prevention
Collins, D. R., Gaiha, G. D., & Walker, B. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0274-9 · Cited by 303
Self-citationFc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
van Erp, E. A., Luytjes, W., Ferwerda, G., & van Kasteren, P. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00548 · Cited by 281
Metadata
- Authors
- Ackerman, M. E., Mikhailova, A., Brown, E. P., Dowell, K. G., Walker, B. D., Bailey-Kellogg, C., Suscovich, T. J., & Alter, G.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-08
- Volume
- 12
- Issue
- 1
- Pages
- e1005315
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2229789789
- Cited by
- 258
- References
- 35
- FWCI
- 27.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.